50 Participants Needed

Functional Electrical Stimulation + Respiratory Muscle Training for Spinal Cord Injury

(AFES and RMT Trial)

GJ
SP
Overseen ByStephane Philippe-Ratway, MS, CCC-SLP
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Miami
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new approach to help people with spinal cord injuries improve their ability to cough independently. The study combines electrical stimulation, which uses small electrical pulses to activate muscles, with training to strengthen breathing muscles. The Xcite Clinical Station delivers the electrical stimulation. There are two treatment groups: one for individuals with paraplegia (paralysis of the lower half of the body) and another for those with tetraplegia (paralysis of all four limbs). Individuals who have had a spinal cord injury for less than a year and can feel muscle contractions from electrical stimulation might be suitable for this trial. As an unphased trial, this study offers a unique opportunity to explore innovative treatments for spinal cord injuries.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the Xcite Clinical Station is safe for individuals with spinal cord injuries?

Research shows that the Xcite Clinical Station, used for abdominal and breathing muscle exercises, is generally safe and well-tolerated. The Xcite system meets important safety standards, ensuring it operates without causing electric shocks or interfering with other devices.

Studies on similar technologies, such as the RISES system for spinal stimulation, have found them safe and practical, with no major side effects reported. Although detailed information on side effects specific to this treatment is limited, the devices' compliance with recognized safety standards offers some reassurance about their safety in humans.

Overall, despite some unknowns, current evidence suggests that the treatment is expected to be safe and well-tolerated.12345

Why are researchers excited about this trial?

Researchers are excited about the combination of Functional Electrical Stimulation (FES) and Respiratory Muscle Training (RMT) for spinal cord injury because this approach offers a novel way to enhance muscle function and breathing capacity. Unlike standard treatments that often focus on rehabilitation through physical therapy alone, this method uses electrical impulses to directly stimulate abdominal muscles, potentially improving muscle strength and respiratory function more effectively. By integrating these two techniques, the treatment could provide quicker and more substantial improvements in both paraplegia and tetraplegia patients, offering new hope for enhanced recovery and quality of life.

What evidence suggests that the Xcite Clinical Station is effective for improving cough in spinal cord injury?

Research has shown that using Functional Electrical Stimulation (FES) with Respiratory Muscle Training (RMT) can improve breathing in people with spinal cord injuries. In this trial, participants will receive co-treatment with abdominal functional electrical stimulation (AFES) and respiratory muscle training (RMT). Studies have found that FES strengthens muscles and improves their function, even after nerve damage. The Xcite Clinical Station uses this method and has shown promise in helping patients regain muscle function by focusing on specific tasks. Early results suggest that this combined therapy may enhance cough strength, which is crucial for clearing airways in people with spinal cord injuries. Overall, evidence supports this approach, showing better outcomes for similar conditions.12678

Who Is on the Research Team?

SP

Stephane Philippe-Ratway, MS, CCC-SLP

Principal Investigator

University of Miami

Are You a Good Fit for This Trial?

This trial is for individuals with acute spinal cord injuries (C2-T12 level, AIS A-C) who are in rehab and were injured less than a year ago. They must respond to electrical stimulation and speak English. It's not for those with severe brain injury, open tracheostomy, pacemakers, pregnancy, epilepsy, wounds or metal at the electrode site, unresponsiveness to electrical stimulation or history of certain cancers.

Inclusion Criteria

My muscles respond to electrical stimulation with a visible contraction.
I am fluent in both written and spoken English.
I have a spinal cord injury between C2-T12 and am in rehab for it.

Exclusion Criteria

Pregnant women
Individuals who do not meet inclusion criteria
You have a tracheostomy that is still open.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive co-treatment with abdominal functional electrical stimulation (AFES) and respiratory muscle training (RMT)

2-4 weeks
Weekly visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Xcite Clinical Station
Trial Overview The study tests if using the Xcite Clinical Station—electrical stimulation on abdominal and latissimus dorsi muscles combined with respiratory muscle training—can improve coughing ability in people with recent spinal cord injuries.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: AFES and RMT Tetraplegia GroupExperimental Treatment1 Intervention
Group II: AFES and RMT Paraplegia GroupExperimental Treatment1 Intervention

Xcite Clinical Station is already approved in United States, European Union for the following indications:

🇺🇸
Approved in United States as Xcite FES Clinical Station for:
🇪🇺
Approved in European Union as Xcite iFES Clinical Station for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

Published Research Related to This Trial

A three-week program of passive abdominal functional electrical stimulation (AFES) significantly increased forced vital capacity (FVC) by 0.36 liters in 12 patients with tetraplegia, indicating improved respiratory function during training.
The study suggests that AFES can be an effective method for respiratory rehabilitation in individuals with tetraplegia, as no significant changes were observed before or after the training period, highlighting the training's specific impact.
Changes in pulmonary function measures following a passive abdominal functional electrical stimulation training program.McLachlan, AJ., McLean, AN., Allan, DB., et al.[2021]
Functional magnetic stimulation (FMS) significantly improved expiratory muscle strength in eight men with tetraplegia after a 4-week training period, with increases in key measures such as maximal expired pressure and expiratory reserve volume.
The improvements in muscle strength were temporary, as the benefits diminished after a 2-week discontinuation of FMS, suggesting that ongoing treatment may be necessary to maintain the gains.
Functional magnetic stimulation for conditioning of expiratory muscles in patients with spinal cord injury.Lin, VW., Hsiao, IN., Zhu, E., et al.[2022]
Functional electrical stimulation (FES) significantly improved cardiovascular fitness, as indicated by increased tidal volume and oxygen consumption during exercise phases, with results showing p-values less than .001.
FES also led to significant increases in thigh girth, suggesting improvements in muscle mass, while demonstrating safety with no serious complications reported, making it an effective intervention for individuals with spinal cord injury.
Functional electric stimulation: its efficacy and safety in improving pulmonary function and musculoskeletal fitness.Arnold, PB., McVey, PP., Farrell, WJ., et al.[2004]

Citations

Functional Electrical Stimulation + Respiratory Muscle ...The Xcite Clinical Station treatment is unique because it combines Functional Electrical Stimulation (FES) with Respiratory Muscle Training, which can help ...
An innovative and activity-based closed-loop framework for ...The RISES system utilizes the FDA-cleared Xcite system for stimulation delivery. The system provides No-Burst stimulation options as part of its ...
3.restorative-therapies.comrestorative-therapies.com/xcite2/
Xcite2Xcite2 was designed to allow clinicians to easily and efficiently apply multi-channel integrated FES with task-specific activities commonly completed in therapy ...
Elevating Neurorehabilitation with Task-Specific FESXcite2 delivers task-specific functional electrical stimulation (FES) that supports neurological recovery from stroke, SCI, brain injury, and more.
Electrical stimulation for the treatment of spinal cord injuriesEpidural electrical stimulation, peripheral nerve stimulation, and functional electrical stimulation have shown promising improvements for individuals with SCI.
Initial feasibility evaluation of the RISES system: An innovative ...This study piloted the safety and feasibility of the Reynolds Innovative Spinal Electrical Stimulation (RISES) technology with a focus on its novel closed-loop ...
K160614 Trade/Device Name: Xcite Cli - accessdata.fda.govThe system complies with Electromagnetic Compatibility and Electrical Safety. The Xcite system conforms to the following standards; IEC60601-1, ...
Investigation Into Optimal FES Training Characteristics ...The aim of this study is to investigate two different modalities of functional electrical stimulation (FES) leg exercise in patients with spinal cord injury ( ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security